• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种HIV-1微型疫苗诱导了长期的细胞免疫和体液免疫反应。

An HIV-1 Mini Vaccine Induced Long-lived Cellular and Humoral Immune Responses.

作者信息

Mahdavi Mehdi, Ebtekar Massoumeh, Hassan Zuhair Mohammad, Faezi Sobhan, Khorram Khorshid Hamidreza, Taghizadeh Morteza, Azadmanesh Keyhan

机构信息

Department of Immunology, Pasteur Institute of Iran, Tehran, Iran.

Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

出版信息

Int J Mol Cell Med. 2015 Fall;4(4):218-26.

PMID:27014646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4769599/
Abstract

Memory formation is the most important aspect of a vaccine which can guarantee long-lasting immunity and protection. The main aim of the present study was to evaluate the memory immune responses after immunization with a mini vaccine. Mice were immunized with human immunodeficiency virus-1 P24-Nef fusion peptide and then cellular and humoral immune responses were evaluated. In order to determine long-lived memory, immune responses were monitored for 20 weeks after final immunization. The results showed that the candidate vaccine induced proliferation and cytotoxic T lymphocyte responses and shifted cytokine patterns to T helper-1 profile. Evaluation of humoral immune responses also showed an increase in total peptide specific-IgG titer and a shift to IgG2a humoral response. Monitoring of immune responses at weeks 4, 12 and 20 after last immunization showed that immunologic parameters have been sustained for 20 weeks. Our findings support the notion that long-lived memory responses were achieved using a mini vaccine immunization.

摘要

记忆形成是疫苗最重要的方面,它能够保证持久的免疫力和保护作用。本研究的主要目的是评估用微型疫苗免疫后的记忆免疫反应。用人类免疫缺陷病毒1型P24-Nef融合肽对小鼠进行免疫,然后评估细胞免疫和体液免疫反应。为了确定长期记忆,在末次免疫后20周监测免疫反应。结果表明,候选疫苗诱导了增殖和细胞毒性T淋巴细胞反应,并使细胞因子模式向辅助性T细胞1型转变。体液免疫反应评估还显示,总肽特异性IgG滴度增加,且体液反应向IgG2a转变。在末次免疫后第4、12和20周监测免疫反应,结果显示免疫参数持续了20周。我们的研究结果支持了这样一种观点,即使用微型疫苗免疫可实现长期记忆反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6d/4769599/f72ca9e29755/ijmcm-4-218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6d/4769599/f72ca9e29755/ijmcm-4-218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6d/4769599/f72ca9e29755/ijmcm-4-218-g001.jpg

相似文献

1
An HIV-1 Mini Vaccine Induced Long-lived Cellular and Humoral Immune Responses.一种HIV-1微型疫苗诱导了长期的细胞免疫和体液免疫反应。
Int J Mol Cell Med. 2015 Fall;4(4):218-26.
2
Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.纳洛酮/明矾混合物是一种有效的HIV-1疫苗佐剂:诱导细胞免疫和多同种型体液免疫反应。
Pathog Glob Health. 2016 Mar;110(2):39-47. doi: 10.1179/2047773215Y.0000000035. Epub 2016 Apr 13.
3
ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.ELISPOT 分析使用 GM-CSF 的新型 CTL 基于 HIV-1 的 DNA 疫苗在 DNA 初免/肽加强策略中的应用:GM-CSF 诱导了持久的记忆反应。
Immunol Lett. 2011 Oct 30;140(1-2):14-20. doi: 10.1016/j.imlet.2011.05.005. Epub 2011 May 23.
4
HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.HIV-1 Gag p24-Nef融合肽在小鼠模型中诱导细胞免疫和体液免疫反应。
Acta Virol. 2010;54(2):131-6. doi: 10.4149/av_2010_02_131.
5
Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.细胞穿透肽与异源DNA初免/蛋白加强策略相结合可增强BALB/c小鼠模型中针对HIV-1 Nef抗原的免疫反应。
Immunol Lett. 2017 Aug;188:38-45. doi: 10.1016/j.imlet.2017.06.003. Epub 2017 Jun 8.
6
Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.Toll样受体5激动剂与HIV-1候选疫苗纳米制剂的联合应用可提高疫苗免疫原性并降低免疫原剂量:一项初步研究。
Immunol Lett. 2017 Jul;187:19-26. doi: 10.1016/j.imlet.2017.05.002. Epub 2017 May 4.
7
Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.Balb/c小鼠对新型HIV-1 p24-gp41/pCAGGS-IL-12 DNA疫苗的免疫反应。
Iran J Immunol. 2012 Jun;9(2):86-97.
8
Adjuvant Effects of Flagellin on the Immunological Patterns of the HIV-1 Vaccine Candidate: Vaccine Formulations Versus Different Routes of Immunization.鞭毛蛋白对 HIV-1 疫苗候选物免疫模式的辅助作用:疫苗制剂与不同免疫途径的比较。
Viral Immunol. 2022 Mar;35(2):150-158. doi: 10.1089/vim.2021.0143.
9
Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.用1型人类免疫缺陷病毒的nef基因对小鼠进行免疫:免疫记忆和长期毒理学研究。
Infect Agent Cancer. 2007 Jul 10;2:14. doi: 10.1186/1750-9378-2-14.
10
Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.用重组牛分枝杆菌卡介苗猿猴免疫缺陷病毒nef进行口服免疫可在小鼠中诱导局部和全身细胞毒性T淋巴细胞反应。
J Virol. 1997 Mar;71(3):2303-9. doi: 10.1128/JVI.71.3.2303-2309.1997.

本文引用的文献

1
ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.ELISPOT 分析使用 GM-CSF 的新型 CTL 基于 HIV-1 的 DNA 疫苗在 DNA 初免/肽加强策略中的应用:GM-CSF 诱导了持久的记忆反应。
Immunol Lett. 2011 Oct 30;140(1-2):14-20. doi: 10.1016/j.imlet.2011.05.005. Epub 2011 May 23.
2
Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.一种新型HIV-1 DNA构建体在BALB/c小鼠模型中的免疫原性。
Iran J Immunol. 2009 Dec;6(4):163-73.
3
Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.
开发一种有效的诱导T细胞的HIV-1疫苗的成功障碍。
J Leukoc Biol. 2009 Oct;86(4):779-93. doi: 10.1189/jlb.0209094. Epub 2009 Jul 13.
4
Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.免疫佐剂:粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素-23(IL-23)对丙型肝炎病毒核心DNA疫苗引发的免疫反应的影响。
Cytokine. 2009 Apr;46(1):43-50. doi: 10.1016/j.cyto.2008.12.007. Epub 2009 Mar 10.
5
A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.一种新型佐剂——通用阿片类拮抗剂纳洛酮,可引发针对DNA疫苗的强烈细胞免疫反应。
Int Immunol. 2009 Mar;21(3):217-25. doi: 10.1093/intimm/dxn139. Epub 2009 Jan 27.
6
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination.对镶嵌型人类免疫缺陷病毒1型包膜DNA疫苗的T细胞应答广度扩大。
J Virol. 2009 Mar;83(5):2201-15. doi: 10.1128/JVI.02256-08. Epub 2008 Dec 24.
7
Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.开发一种HIV细胞毒性T淋巴细胞疫苗:CD8 T细胞数量、质量和定位问题。
J Intern Med. 2009 Jan;265(1):125-37. doi: 10.1111/j.1365-2796.2008.02054.x.
8
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.在一项I期试验中,含或不含GM-CSF的HIV细胞毒性T淋巴细胞多表位肽疫苗的安全性和免疫原性。
Vaccine. 2009 Jan 7;27(2):243-9. doi: 10.1016/j.vaccine.2008.10.051. Epub 2008 Nov 7.
9
Towards prediction of degenerate CTL epitope recognition.迈向对退化性细胞毒性T淋巴细胞表位识别的预测。
Hum Vaccin. 2008 Mar-Apr;4(2):115-21. doi: 10.4161/hv.4.2.5215. Epub 2007 Oct 26.
10
T-cell quality in memory and protection: implications for vaccine design.记忆与保护中的T细胞质量:对疫苗设计的启示
Nat Rev Immunol. 2008 Apr;8(4):247-58. doi: 10.1038/nri2274. Epub 2008 Mar 7.